Pharmaceuticals

Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial

Why Health Care Stocks Are Soaring: A Close‑Look at the Momentum

America's Shifting Sands: Unpacking the US Drive to Reduce Reliance on China

Aurobindo Pharma Scores Major USFDA Win with Generic Tofacitinib Tablets

Unearthing Hidden Value: Why Small-Cap US Healthcare Stocks Deserve a Closer Look

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur

Day 2 Highlights from ASCO 2026: Breakthroughs from BioNTech, Pfizer, Kelun, Merck and Insights by Dr. Eric Pazdur

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

The Unveiling of Trump's Most Favored Nation Drug Pricing Secrets

Imagine This: One Shot, Drastically Lower Cholesterol. A Game-Changer on the Horizon?

FDA Chief Kyle Diamantas Hails NIH’s Quick Fix to Leadership Gap Amid DC Health Concerns

Kyle Diamantas Shines as Acting FDA Commissioner, Winning Trust Across the Board

The Humira Enigma: How a Patent Fortress Redefined Pharma Monopolies

A Nation's Health: Recalling President Trump's Stance on American Medical Prowess

Aurobindo Pharma Faces Significant Regulatory Hurdle as USFDA Flags Telangana Facility as 'Official Action Indicated'

Igniting Innovation: CSIR-IIIM Jammu Hosts Renowned French Scientist to Propel Drug Discovery

The Quiet Influence: Pharma's Play in Shaping Policy

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

Battle Lines Drawn: UK Health Advocates Prepare for Legal Fight Over US Pharma Trade Deal

India's Export Story: A Global Trade Twist No One Saw Coming

A Game Changer for Canadians? Dr. Reddy's Unveils Generic Semaglutide Injection

JB Chemicals & Pharmaceuticals: A Look at Their March 2026 Financials

Neurocrine Biosciences: A Biotech Balancing Stable Growth with a Bold, Risky Bet

Navigating the Dragon's Den: China's Evolving Role in Global Biotech

Merck's Bold Bet: A Deep Dive into the Pipeline Powering Post-Keytruda Growth

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

A Collective Sigh of Relief: Health Minister Confirms Robust Medicine Supplies for Months Ahead

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

A Digital Pioneer Departs: Andrew Baum's Exit from Pfizer

The Psychedelic Crossroads: Hope, Science, and the Shadow of Politics

Lilly's Strategic Gambit: Unpacking the Kelonia Therapeutics Partnership

Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance

Biocon's Bold Vision: Charting a Course for Global Insulin Leadership

The Biotech Tango: Why Merck Pumped the Brakes on Terns Pharmaceuticals' Acquisition

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

The Unspoken Irony: RFK Jr.'s Medical Freedom Paradox

President Trump Unveils Major Tariff Actions, Reinforcing Economic Nationalism on 'Liberation Day' Anniversary